PR Newswire Asia's news > Medical/Pharmaceuticals

 < Previous page   |   Detail   |   Print    Next page > 
     
Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC Published in The Lancet
2026-05-31T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
The Results of Phase III OptiTROP-Lung05 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ASCO Oral Presentation and Simultaneously Published in The Lancet
2026-05-30T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Kelun-Biotech Presents Pivotal Phase II Data for Lunbotinib Fumarate (A400/EP0031) in RET Fusion-Positive NSCLC at 2026 ASCO
2026-05-30T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Duke-NUS graduates biggest class yet, with new doctors drawn from business, engineering and the humanities
2026-05-30T    Education   Health Care/Hospital   Higher Education   Medical/Pharmaceuticals 
XtalPi Receives Second Payment from DoveTree; First Oncology Asset Advances into IND-Enabling Studies
2026-05-29T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Innogen to Present Phase IIb ENLIGHT Study Results for Efsubaglutide Alfa at the 2026 ADA Scientific Sessions
2026-05-29T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Holmusk Expands NeuroBlu to 46 Million Patients, Adding Depth and Biomarker Data Across Neurology and Behavioral Health
2026-05-29T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
SKIA HEAD: AR Surgical Guidance Receives FDA 510(k) Clearance, Eyes U.S. Expansion with Structure Partnership
2026-05-29T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Dizal Announces Phase 3 WU-KONG28 Results: ZEGFROVY® (Sunvozertinib) Outperforms Platinum-Doublet Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation-Positive Non-Small Cell Lung Cancer
2026-05-29T    Health Care/Hospital   Medical/Pharmaceuticals 
CooperVision Names Muru Annamalai as President, Asia-Pacific
2026-05-29T    Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.